Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CCR7 antibody drug conjugates

Anti-CCR7 antibody drug conjugates

US Patent 12180291 · Granted Dec 31, 2024

Estimated economic value: $84,960,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
System for fluid transfer2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Antibody drug conjugates for ablating hematopoietic stem cells2024
Antibody drug conjugates for ablating hematopoietic stem cells2024
Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer2024
ENTPD2 antibodies, combination therapies, and methods of using the antibodies an2024
ENTPD2 antibodies, combination therapies, and methods of using the antibodies an2024
ENTPD2 antibodies, combination therapies, and methods of using the antibodies an2024
Antibody-cytokine engrafted proteins and methods of use for immune related disor2024
mRNA-mediated immunization methods2024
CKIT antibody drug conjugates2023